Prevalence of IgA deficiency in children with juvenile rheumatoid arthritis. 2011

Mohammad Hasan Moradinejad, and Ali Hoseinpoor Rafati, and Maryam Ardalan, and Mahnaz Rabiei, and Maryam Farghadan, and Mohammad Taghi Haghi Ashtiani, and Zahra Pourpak, and Mostafa Moin
Department of Rheumatology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.

The purpose of this study was to investigate any association between IgA deficiency (IgAD) and juvenile rheumatoid arthritis (JRA) among Iranian children.This case-control study was carried out on 83 children who were diagnosed as JRA according to American College of Rheumatology (ACR) criteria; Patients were admitted at the rheumatology clinic of Children's Medical Center, (Tehran). Serum immunoglobulins concentrations were determined by nephelometry method. Control group was 112 healthy children who were matched for age and gender. Informed consent obtained from all parents.Selective IgA deficiency (sIgAD) was found only in a boy (1.2%) among JRA children; however, partial IgA deficiency was found in 6(7.1%) of patients with JRA and in 12(10.7%) of control subjects, this difference was not statistically significant (p=0.46). Immunoglobulins levels in patients with JRA (IgM: 126.7±57.2, IgG: 1182.3±351 and IgA:169.3±98) were significantly higher than their controls (IgM: 104±52, IgG:802±220 and IgA: 94.6±47) (p<0.05). Patients with growth failure had higher IgM, IgG and IgA levels in comparison with patients without growth failure; however, this difference was significant about IgM and IgG levels (p<0.05).In contrast to other similar studies, the number of IgAD did not differ significantly between JRA patients and their control counterpart; this might be partly due to the high rate of consanguineous marriages in Iran that resulted in increased prevalence of clinically undiagnosed partial IgAD in general population. Hence, future epidemiological studies are warranted to make it clear.

UI MeSH Term Description Entries
D007136 Immunoglobulins Multi-subunit proteins which function in IMMUNITY. They are produced by B LYMPHOCYTES from the IMMUNOGLOBULIN GENES. They are comprised of two heavy (IMMUNOGLOBULIN HEAVY CHAINS) and two light chains (IMMUNOGLOBULIN LIGHT CHAINS) with additional ancillary polypeptide chains depending on their isoforms. The variety of isoforms include monomeric or polymeric forms, and transmembrane forms (B-CELL ANTIGEN RECEPTORS) or secreted forms (ANTIBODIES). They are divided by the amino acid sequence of their heavy chains into five classes (IMMUNOGLOBULIN A; IMMUNOGLOBULIN D; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M) and various subclasses. Globulins, Immune,Immune Globulin,Immune Globulins,Immunoglobulin,Globulin, Immune
D007492 Iran A country bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. The capital is Tehran. Islamic Republic of Iran
D008297 Male Males
D009391 Nephelometry and Turbidimetry Chemical analysis based on the phenomenon whereby light, passing through a medium with dispersed particles of a different refractive index from that of the medium, is attenuated in intensity by scattering. In turbidimetry, the intensity of light transmitted through the medium, the unscattered light, is measured. In nephelometry, the intensity of the scattered light is measured, usually, but not necessarily, at right angles to the incident light beam. Turbidimetry,Nephelometry,Turbidimetry and Nephelometry
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D006130 Growth Disorders Deviations from the average values for a specific age and sex in any or all of the following: height, weight, skeletal proportions, osseous development, or maturation of features. Included here are both acceleration and retardation of growth. Stunted Growth,Stunting,Disorder, Growth,Growth Disorder,Growth, Stunted,Stuntings
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Mohammad Hasan Moradinejad, and Ali Hoseinpoor Rafati, and Maryam Ardalan, and Mahnaz Rabiei, and Maryam Farghadan, and Mohammad Taghi Haghi Ashtiani, and Zahra Pourpak, and Mostafa Moin
January 1983, Scandinavian journal of rheumatology,
Mohammad Hasan Moradinejad, and Ali Hoseinpoor Rafati, and Maryam Ardalan, and Mahnaz Rabiei, and Maryam Farghadan, and Mohammad Taghi Haghi Ashtiani, and Zahra Pourpak, and Mostafa Moin
July 1981, Japanese journal of medicine,
Mohammad Hasan Moradinejad, and Ali Hoseinpoor Rafati, and Maryam Ardalan, and Mahnaz Rabiei, and Maryam Farghadan, and Mohammad Taghi Haghi Ashtiani, and Zahra Pourpak, and Mostafa Moin
January 1972, Clinical and experimental immunology,
Mohammad Hasan Moradinejad, and Ali Hoseinpoor Rafati, and Maryam Ardalan, and Mahnaz Rabiei, and Maryam Farghadan, and Mohammad Taghi Haghi Ashtiani, and Zahra Pourpak, and Mostafa Moin
April 1967, American journal of diseases of children (1960),
Mohammad Hasan Moradinejad, and Ali Hoseinpoor Rafati, and Maryam Ardalan, and Mahnaz Rabiei, and Maryam Farghadan, and Mohammad Taghi Haghi Ashtiani, and Zahra Pourpak, and Mostafa Moin
January 1990, Clinical and experimental rheumatology,
Mohammad Hasan Moradinejad, and Ali Hoseinpoor Rafati, and Maryam Ardalan, and Mahnaz Rabiei, and Maryam Farghadan, and Mohammad Taghi Haghi Ashtiani, and Zahra Pourpak, and Mostafa Moin
January 1999, Rheumatology international,
Mohammad Hasan Moradinejad, and Ali Hoseinpoor Rafati, and Maryam Ardalan, and Mahnaz Rabiei, and Maryam Farghadan, and Mohammad Taghi Haghi Ashtiani, and Zahra Pourpak, and Mostafa Moin
October 1983, The Journal of rheumatology,
Mohammad Hasan Moradinejad, and Ali Hoseinpoor Rafati, and Maryam Ardalan, and Mahnaz Rabiei, and Maryam Farghadan, and Mohammad Taghi Haghi Ashtiani, and Zahra Pourpak, and Mostafa Moin
January 1973, Pediatrics,
Mohammad Hasan Moradinejad, and Ali Hoseinpoor Rafati, and Maryam Ardalan, and Mahnaz Rabiei, and Maryam Farghadan, and Mohammad Taghi Haghi Ashtiani, and Zahra Pourpak, and Mostafa Moin
September 1990, The Journal of rheumatology,
Mohammad Hasan Moradinejad, and Ali Hoseinpoor Rafati, and Maryam Ardalan, and Mahnaz Rabiei, and Maryam Farghadan, and Mohammad Taghi Haghi Ashtiani, and Zahra Pourpak, and Mostafa Moin
January 1991, Clinical and experimental rheumatology,
Copied contents to your clipboard!